Manufacture of pharmaceutical preparations
NORSK MEDISINSK SYKLOTRONSENTER AS
Revenue 2024
NOK 108.3m
Operating profit
NOK −3.1m
Equity
NOK 13.7m
Incorporated
2003
Employees
54
Share capital
NOK 500,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 108.3m | |
| Total operating costs | 111.4m | |
| Operating profit (EBIT) | −3.1m | |
| Net financial items | −1.8m | |
| Profit for the year | −4.3m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 67.8m | |
| of which current assets | 20.1m | |
| Equity | 13.7m | |
| Total liabilities | 54.2m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.